Rongcan Bio
Shanghai
About Rongcan Bio
Rongcan Bio completes the nucleic acid industry chain from nucleic acid sequence design, mRNA nucleic acid raw material synthesis, delivery carrier synthesis, and final drug delivery. It is a nucleic acid drug development and industrialization service provider.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $14.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2023)
- Website: rc-rna.com
- Phone: 021-68097058
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/rongcan-bio-35901 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.